| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR PUT | 400,000 | 81,548,000 | 11.94% | Put | |
| 2 | TEVA PHARMACEUTICAL INDS LTD | 784,850 | 51,517,000 | 7.54% | ||
| 3 | ORMAT TECHNOLOGIES INC | 272,462 | 38,744,000 | 5.67% | ||
| 4 | PFIZER INC | 1,176,612 | 37,981,000 | 5.56% | ||
| 5 | BIOGEN INC | 123,850 | 37,941,000 | 5.56% | ||
| 6 | ALLERGAN PLC | 100,000 | 31,250,000 | 4.58% | ||
| 7 | SPDR S&P BIOTECH ETF | 329,800 | 23,152,000 | 3.39% | Put | |
| 8 | ABBVIE INC | 362,000 | 21,445,000 | 3.14% | ||
| 9 | CELGENE CORP | 147,200 | 17,629,000 | 2.58% | ||
| 10 | MYLAN N.V. | 300,000 | 16,221,000 | 2.37% | Call | |
| 11 | GILEAD SCIENCES INC | 142,700 | 14,440,000 | 2.11% | ||
| 12 | ALEXION PHARMACEUTIC | 59,164 | 11,286,000 | 1.65% | ||
| 13 | BRISTOL MYERS SQUIBB CO | 121,500 | 8,358,000 | 1.22% | ||
| 14 | SHIRE PLC | 40,000 | 8,200,000 | 1.20% | ||
| 15 | ACORDA THERAPEUTICS | 143,000 | 6,118,000 | 0.90% | ||
| 16 | VERTEX PHARMACEUT | 48,400 | 6,090,000 | 0.89% | ||
| 17 | FIVE PRIME THERAPEUTICS INC | 145,000 | 6,018,000 | 0.88% | ||
| 18 | ISHARES NASDAQ BIOTECHNOLOGY ETF | 7,409 | 5,764,000 | 0.84% | ||
| 19 | INCYTE | 51,621 | 5,598,000 | 0.82% | ||
| 20 | SAGE THERAPEUTICS | 93,000 | 5,422,000 | 0.79% | ||
| 21 | CELLCOM ISRAEL LTD | 212,300 | 5,144,000 | 0.75% | ||
| 22 | IONIS PHARMACEUTICALS INC | 81,200 | 5,029,000 | 0.74% | ||
| 23 | OPKO HEALTH INC | 500,000 | 5,025,000 | 0.74% | ||
| 24 | MACROGENICS INC | 153,000 | 4,738,000 | 0.69% | ||
| 25 | BELLICUM PHARMACEUTICALS INC COM | 231,515 | 4,693,000 | 0.69% | ||
| 26 | CHECK POINT SOFTWARE TECH LT | 55,857 | 4,546,000 | 0.67% | ||
| 27 | PORTOLA PHARMACEUTICALS INC | 85,500 | 4,399,000 | 0.64% | ||
| 28 | MARINUS PHARMACEUTICALS INC | 570,908 | 4,362,000 | 0.64% | ||
| 29 | RADIUS HEALTH | 70,000 | 4,308,000 | 0.63% | ||
| 30 | VANDA PHARMACEUTICALS INC COM | 462,051 | 4,302,000 | 0.63% | ||
| 31 | ADAMAS PHARMACEUTICALS INC | 150,000 | 4,248,000 | 0.62% | ||
| 32 | INOTEK PHARMACEUTICALS CORP | 360,000 | 4,079,000 | 0.60% | ||
| 33 | ALNYLAM PHARMACEUTICALS INC | 40,000 | 3,766,000 | 0.55% | ||
| 34 | ALDER BIOPHARMACEUTICALS INC | 112,500 | 3,716,000 | 0.54% | ||
| 35 | ORBOTECH LTD | 167,619 | 3,709,000 | 0.54% | ||
| 36 | KEMPHARM INC | 183,954 | 3,653,000 | 0.53% | ||
| 37 | HERON THERAPEUTICS INC | 135,000 | 3,605,000 | 0.53% | ||
| 38 | GOOGLE INC | 4,600 | 3,579,000 | 0.52% | Call | |
| 39 | ACADIA PHARMACEUTICALS INC COM | 100,000 | 3,565,000 | 0.52% | ||
| 40 | CATALYST PHARMACEUTICALS INC | 1,455,000 | 3,565,000 | 0.52% | ||
| 41 | RAPTOR PHARMACEUTICAL CORP | 685,000 | 3,562,000 | 0.52% | ||
| 42 | GW PHARMACEUTICALS PLC | 50,000 | 3,472,000 | 0.51% | Call | |
| 43 | VALEANT PHARMACEUTICALS INTL | 33,750 | 3,431,000 | 0.50% | ||
| 44 | CONCERT PHARMACEUTICALS INC COM | 180,000 | 3,415,000 | 0.50% | ||
| 45 | TJX COS INC NEW | 47,961 | 3,401,000 | 0.50% | ||
| 46 | Anacor Pharmaceuticals Inc | 30,000 | 3,389,000 | 0.50% | ||
| 47 | ADURO BIOTECH | 120,000 | 3,377,000 | 0.49% | ||
| 48 | NOVAVAX INC COM | 400,000 | 3,356,000 | 0.49% | ||
| 49 | CARA THERAPEUTICS INC | 197,820 | 3,335,000 | 0.49% | ||
| 50 | CLOVIS ONCOLOGY INC | 94,500 | 3,308,000 | 0.48% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-16-004256, filed 2016.02.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
